Your browser doesn't support javascript.
loading
The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy-a multicenter retrospective analysis.
Spohn, Simon K B; Farolfi, Andrea; Schandeler, Sarah; Vogel, Marco M E; Ruf, Juri; Mix, Michael; Kirste, Simon; Ceci, Francesco; Fanti, Stefano; Lanzafame, Helena; Serani, Francesca; Gratzke, Christian; Sigle, August; Combs, Stephanie E; Bernhardt, Denise; Gschwend, Juergen E; Buchner, Josef A; Trapp, Christian; Belka, Claus; Bartenstein, Peter; Unterrainer, Lena; Unterrainer, Marcus; Eiber, Matthias; Nekolla, Stephan G; Schiller, Kilian; Grosu, Anca L; Schmidt-Hegemann, Nina-Sophie; Zamboglou, Constantinos; Peeken, Jan C.
Afiliação
  • Spohn SKB; Department of Radiation Oncology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Robert-Koch-Straße 3, 79106, Freiburg, Germany. Simon.Spohn@uniklinik-freiburg.de.
  • Farolfi A; German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany. Simon.Spohn@uniklinik-freiburg.de.
  • Schandeler S; Berta-Ottenstein-Programme, Faculty of Medicine, University of Freiburg, Freiburg, Germany. Simon.Spohn@uniklinik-freiburg.de.
  • Vogel MME; Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.
  • Ruf J; Department of Radiation Oncology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Robert-Koch-Straße 3, 79106, Freiburg, Germany.
  • Mix M; Department of Radiation Oncology, Klinikum Rechts Der Isar, Technical University of Munich, Munich, Germany.
  • Kirste S; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
  • Ceci F; Department of Nuclear Medicine, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany.
  • Fanti S; Department of Nuclear Medicine, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany.
  • Lanzafame H; Department of Radiation Oncology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Robert-Koch-Straße 3, 79106, Freiburg, Germany.
  • Serani F; German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany.
  • Gratzke C; Division of Nuclear Medicine, IEO European Institute of Oncology Scientific IRCCS, Milan, Italy.
  • Sigle A; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Combs SE; Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.
  • Bernhardt D; Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.
  • Gschwend JE; Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.
  • Buchner JA; Department of Urology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Trapp C; Department of Urology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Belka C; Department of Radiation Oncology, Klinikum Rechts Der Isar, Technical University of Munich, Munich, Germany.
  • Bartenstein P; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
  • Unterrainer L; Institute of Radiation Medicine, Helmholtz Zentrum München, Munich, Germany.
  • Unterrainer M; Department of Radiation Oncology, Klinikum Rechts Der Isar, Technical University of Munich, Munich, Germany.
  • Eiber M; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
  • Nekolla SG; Department of Urology, Klinikum Rechts Der Isar, Technical University of Munich, Munich, Germany.
  • Schiller K; Department of Radiation Oncology, Klinikum Rechts Der Isar, Technical University of Munich, Munich, Germany.
  • Grosu AL; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
  • Schmidt-Hegemann NS; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.
  • Zamboglou C; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
  • Peeken JC; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.
Eur J Nucl Med Mol Imaging ; 50(1): 218-227, 2022 Dec.
Article em En | MEDLINE | ID: mdl-35984452
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: Eur J Nucl Med Mol Imaging Assunto da revista: MEDICINA NUCLEAR Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: Eur J Nucl Med Mol Imaging Assunto da revista: MEDICINA NUCLEAR Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha